The benefits that get far less attention may matter just as much for long-term health
The FDA closely monitors all GLP-1 drugs, especially concerning unapproved, compounded, and counterfeit products
Potential Muscle Loss Recovery Weight loss involves losing some muscle along with fat
The difference is that while liraglutide and Semaglutide are reversible through the binding of fatty acids to HSA and their GLP-1 drug molecules can act independently of HSA, albiglutide is genetically engineered to express two GLP-1 molecules fused to HSA in a tandem repeat to form a new protein molecule in a similar manner to dulaglutide
Understanding potential interactions between Wegovy (semaglutide), a GLP-1 receptor agonist, and these common cold medications is essential for safe symptom management
Two have regulatory histories worth knowing: BPI Labs received an FDA warning letter in March 2025, and Olympia Pharmaceuticals received an FDA Form 483 in May 2024